Meeting
2017 Gastrointestinal Cancers Symposium
Impact of clinical and molecular features on risk of recurrence following curative intent resection of metastases in metastatic colorectal cancer.
Authors
Matthew E. Burge
Royal Brisbane and Women's Hospital, Herston, Australia
Matthew E. Burge , Belinda Lee , Margaret Lee , Rachel Wong , Phillip Parente , Jayesh Desai , Ben Tran , Louise M. Nott , Jeremy David Shapiro , Gary Edward Richardson , Allan Solomon Zimet , Peter Gibbs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 785)
DOI
10.1200/JCO.2017.35.4_suppl.785
Abstract #
785
Poster Bd #
N7
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Variable implementation of optimal therapeutic strategies in metastatic colorectal cancer: Reviewing rates of liver resection and triplet chemotherapy across Australian hospitals as potential quality indicators.
First Author: Catherine Dunn
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Risk of relapse and patient selection for metastatic colorectal cancer liver surgery.
First Author: Madalena Machete
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of early tumor shrinkage and depth of response in patients with BRAF V600E-mutant metastatic colorectal cancer.
First Author: Shohei Udagawa
Poster
2022 ASCO Annual Meeting
HER3 expression in metastatic colorectal cancer: Defining the clinicomolecular profile of an emerging target.
First Author: Alisha Heather Bent